ArticleAntibiotics (Basel, Switzerland)2020

3-(5-Nitrofuran-2-yl)prop-2-en-1-one Derivatives, with Potent Antituberculosis Activity, Inhibit A Novel Therapeutic Target, Arylamine

Neha Agre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.